199 related articles for article (PubMed ID: 37257708)
21. Role of succinate in airway epithelial cell regulation following traumatic lung injury.
Suresh MV; Aktay S; Yalamanchili G; Solanki S; Sathyarajan DT; Arnipalli MS; Pennathur S; Raghavendran K
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737265
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.
Xu S; Little PJ; Lan T; Huang Y; Le K; Wu X; Shen X; Huang H; Cai Y; Tang F; Wang H; Liu P
Arch Biochem Biophys; 2011 Nov; 515(1-2):72-9. PubMed ID: 21889487
[TBL] [Abstract][Full Text] [Related]
23. Sodium Danshensu stabilizes atherosclerotic vulnerable plaques by targeting IKKβ mediated inflammation in macrophages.
Zeng M; Zhang X; Lv N; Wang L; Suo Y; Gan J; Yang L; Yu B; Jiang X; Zeng W
Biomed Pharmacother; 2023 Sep; 165():115153. PubMed ID: 37437377
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells.
Jin H; Peng X; He Y; Ruganzu JB; Yang W
Brain Res Bull; 2020 Nov; 164():136-145. PubMed ID: 32860868
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA reduces oxidized low-density lipoprotein-induced inflammatory responses by downregulating microRNA-33 in THP-1 macrophages.
Yang C; Lei X; Li J
Int J Clin Exp Pathol; 2019; 12(10):3791-3798. PubMed ID: 31933767
[TBL] [Abstract][Full Text] [Related]
27. Systemic Succinate, Hypoxia-Inducible Factor-1 Alpha, and IL-1β Gene Expression in Autosomal Dominant Polycystic Kidney Disease with and without Hypertension.
Kocyigit I; Taheri S; Eroglu E; Sener EF; Zararsız G; Uzun I; Tufan E; Mehmetbeyoglu E; Korkmaz Bayramov K; Sipahioglu MH; Ozkul Y; Tokgoz B; Oymak O; Axelsson J
Cardiorenal Med; 2019; 9(6):370-381. PubMed ID: 31319406
[TBL] [Abstract][Full Text] [Related]
28. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
[TBL] [Abstract][Full Text] [Related]
29. Exploring the synergistic mechanism of Gegen Qinlian Decoction on the Wnt signaling pathway using an integrated strategy of network pharmacology and RNA-seq.
Li Y; Gong Y; Zhang X; Wang J; Cheng Y; Liu F; Shi X; Xu W; Dong L
J Ethnopharmacol; 2021 Oct; 278():114283. PubMed ID: 34098017
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet.
Fang ZY; Lin R; Yuan BX; Liu Y; Zhang H
Life Sci; 2007 Oct; 81(17-18):1339-45. PubMed ID: 17942126
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL.
Wang B; Ge Z; Cheng Z; Zhao Z
Biol Open; 2017 Apr; 6(4):489-495. PubMed ID: 28412716
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.
Fu P; Du F; Chen W; Yao M; Lv K; Liu Y
Oncol Rep; 2014 Jun; 31(6):2561-8. PubMed ID: 24737252
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially
Chen Z; Gao X; Jiao Y; Qiu Y; Wang A; Yu M; Che F; Li S; Liu J; Li J; Zhang H; Yu C; Li G; Gao Y; Pan L; Sun W; Guo J; Cao B; Zhu Y; Xu H
Front Pharmacol; 2019; 10():850. PubMed ID: 31402870
[No Abstract] [Full Text] [Related]
34. Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway.
Tang JJ; Li GX; Liu ZG; Yi R; Yu D; Zhang YB; Zhao SQ; Wang SH
Chin J Integr Med; 2022 Jun; 28(6):509-517. PubMed ID: 32623702
[TBL] [Abstract][Full Text] [Related]
35. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
36. Mechanism exploration of 6-Gingerol in the treatment of atherosclerosis based on network pharmacology, molecular docking and experimental validation.
Hu Y; Liu T; Zheng G; Zhou L; Ma K; Xiong X; Zheng C; Li J; Zhu Y; Bian W; Zheng X; Xiong Q; Lin J
Phytomedicine; 2023 Jul; 115():154835. PubMed ID: 37121058
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1α and NFκB Transcription Factors.
Filippi I; Carraro F; Naldini A
Mediators Inflamm; 2015; 2015():789414. PubMed ID: 26696754
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D/VDR signaling inhibits LPS-induced IFNγ and IL-1β in Oral epithelia by regulating hypoxia-inducible factor-1α signaling pathway.
Ge X; Wang L; Li M; Xu N; Yu F; Yang F; Li R; Zhang F; Zhao B; Du J
Cell Commun Signal; 2019 Feb; 17(1):18. PubMed ID: 30813930
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α.
Naldini A; Filippi I; Miglietta D; Moschetta M; Giavazzi R; Carraro F
Eur J Cancer; 2010 Dec; 46(18):3400-8. PubMed ID: 20801015
[TBL] [Abstract][Full Text] [Related]
40. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
